|
USP31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.326400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.529800E-02 |
| Normal-vs-Stage2 |
3.871000E-01 |
| Normal-vs-Stage3 |
6.209600E-02 |
| Normal-vs-Stage4 |
6.280000E-03 |
| Stage1-vs-Stage2 |
7.639800E-01 |
| Stage1-vs-Stage3 |
5.610600E-01 |
| Stage1-vs-Stage4 |
1.121220E-01 |
| Stage2-vs-Stage3 |
5.325200E-01 |
| Stage2-vs-Stage4 |
1.346600E-01 |
| Stage3-vs-Stage4 |
3.399000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.210410E-02 |
| Normal-vs-AfricanAmerican |
2.143000E-01 |
| Normal-vs-Asian |
7.193700E-02 |
| Caucasian-vs-AfricanAmerican |
9.248400E-01 |
| Caucasian-vs-Asian |
9.217000E-01 |
| AfricanAmerican-vs-Asian |
9.839000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.734960E-01 |
| Normal-vs-Female |
1.714370E-02 |
| Male-vs-Female |
4.577600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.420100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.617500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.385600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.211000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.513400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.018000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.345400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.481400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.352000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.255800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.672200E-02 |
| Classical-VS-Follicular |
5.29429999951425E-07 |
| Classical-VS-Other |
4.407000E-01 |
| Classical-VS-Normal |
1.177600E-03 |
| Tall-VS-Follicular |
1.55890999999908E-05 |
| Tall-VS-Other |
1.401990E-01 |
| Tall-VS-Normal |
1.998460E-03 |
| Follicular-VS-Other |
3.701600E-01 |
| Follicular-VS-Normal |
1.090000E-01 |
| Other-VS-Normal |
7.325400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.636600E-01 |
| Normal-vs-N1 |
5.370000E-02 |
| N0-vs-N1 |
2.168100E-02 |
|
|
